Illumina draws antitrust complaint from life-sciences firms over genome-sequencing patents
MLex Summary: Illumina is facing antitrust claims from life-sciences firms Complete Genomics, BGI and MGI accusing it of illegally obtaining patents and enforcing them in an anticompetitive manner. The complaint cites...To view the full article, register now.
Already a subscriber? Click here to view full article